170 related articles for article (PubMed ID: 12235279)
21. Changes in nociceptin/orphanin FQ levels in rat brain regions after acute and chronic cannabinoid treatment in conjunction with the development of antinociceptive tolerance.
Ulugol A; Topuz RD; Gunduz O; Kizilay G; Karadag HC
Fundam Clin Pharmacol; 2016 Dec; 30(6):537-548. PubMed ID: 27371029
[TBL] [Abstract][Full Text] [Related]
22. Possible involvement of endogenous nociceptin/orphanin FQ in the pain-related behavioral responses induced by its own metabolite, nociceptin/orphanin FQ(14-17).
Watanabe H; Mizoguchi H; Orito T; Katsuyama S; Yonezawa A; Watanabe C; Sakurada T; Sakurada S
Peptides; 2007 Mar; 28(3):670-7. PubMed ID: 17196303
[TBL] [Abstract][Full Text] [Related]
23. Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice.
Kamei J; Ohsawa M; Kashiwazaki T; Nagase H
Eur J Pharmacol; 1999 Apr; 370(2):109-16. PubMed ID: 10323258
[TBL] [Abstract][Full Text] [Related]
24. Activation of opioid receptor like-1 receptor in the spinal cord produces sex-specific antinociception in the rat: estrogen attenuates antinociception in the female, whereas testosterone is required for the expression of antinociception in the male.
Claiborne J; Nag S; Mokha SS
J Neurosci; 2006 Dec; 26(50):13048-53. PubMed ID: 17167094
[TBL] [Abstract][Full Text] [Related]
25. Intrathecal administration of low-dose nociceptin/orphanin FQ induces allodynia via c-Jun N-terminal kinase and monocyte chemoattractant protein-1.
Kawabata K; Nishimura I; Fujiwara T; Terauchi S; Minami T; Ito S; Okuda-Ashitaka E
Eur J Neurosci; 2016 Jun; 43(11):1499-508. PubMed ID: 27038234
[TBL] [Abstract][Full Text] [Related]
26. Synergistic anti-allodynic effects of nociceptin/orphanin FQ and cannabinoid systems in neuropathic mice.
Gunduz O; Karadag HC; Ulugol A
Pharmacol Biochem Behav; 2011 Oct; 99(4):540-4. PubMed ID: 21664922
[TBL] [Abstract][Full Text] [Related]
27. The nociceptin/orphanin FQ receptor ligand acetyl-RYYRIK-amide exhibits antagonistic and agonistic properties.
Berger H; Bigoni R; Albrecht E; Richter RM; Krause E; Bienert M; Calo' G
Peptides; 2000 Jul; 21(7):1131-9. PubMed ID: 10998548
[TBL] [Abstract][Full Text] [Related]
28. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats.
Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G
Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616
[TBL] [Abstract][Full Text] [Related]
29. Nociceptin receptor antagonist JTC-801 inhibits nitrous oxide-induced analgesia in mice.
Koyama T; Fukuda K
J Anesth; 2009; 23(2):301-3. PubMed ID: 19444578
[TBL] [Abstract][Full Text] [Related]
30. Regulation of proinflammatory cytokines gene expression by nociceptin/orphanin FQ in the spinal cord and the cultured astrocytes.
Fu X; Zhu ZH; Wang YQ; Wu GC
Neuroscience; 2007 Jan; 144(1):275-85. PubMed ID: 17069983
[TBL] [Abstract][Full Text] [Related]
31. Antinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys.
Ko MC; Naughton NN
J Pain; 2009 May; 10(5):509-16. PubMed ID: 19231294
[TBL] [Abstract][Full Text] [Related]
32. Modulation of synaptic transmission by nociceptin/orphanin FQ and nocistatin in the spinal cord dorsal horn of mutant mice lacking the nociceptin/orphanin FQ receptor.
Ahmadi S; Kotalla C; Gühring H; Takeshima H; Pahl A; Zeilhofer HU
Mol Pharmacol; 2001 Mar; 59(3):612-8. PubMed ID: 11179457
[TBL] [Abstract][Full Text] [Related]
33. UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ: behavioral and electrophysiological studies in mice.
Nazzaro C; Rizzi A; Salvadori S; Guerrini R; Regoli D; Zeilhofer HU; Calo G
Peptides; 2007 Mar; 28(3):663-9. PubMed ID: 17161885
[TBL] [Abstract][Full Text] [Related]
34. Orphanin FQ/nociceptin modulates glutamate- and kainic acid-induced currents in acutely isolated rat spinal dorsal horn neurons.
Shu YS; Zhao ZQ; Li MY; Zhou GM
Neuropeptides; 1998 Dec; 32(6):567-71. PubMed ID: 9920456
[TBL] [Abstract][Full Text] [Related]
35. Involvement of nociceptin/orphanin FQ and its receptor in electroacupuncture-produced anti-hyperalgesia in rats with peripheral inflammation.
Fu X; Wang YQ; Wu GC
Brain Res; 2006 Mar; 1078(1):212-8. PubMed ID: 16563360
[TBL] [Abstract][Full Text] [Related]
36. Nociceptin/orphanin FQ: role in nociceptive information processing.
Yamamoto T; Nozaki-Taguchi N; Sakashita Y; Kimura S
Prog Neurobiol; 1999 Apr; 57(5):527-35. PubMed ID: 10215100
[TBL] [Abstract][Full Text] [Related]
37. Evidence for an exclusive antinociceptive effect of nociceptin/orphanin FQ, an endogenous ligand for the ORL1 receptor, in two animal models of neuropathic pain.
Courteix C; Coudoré-Civiale MA; Privat AM; Pélissier T; Eschalier A; Fialip J
Pain; 2004 Jul; 110(1-2):236-45. PubMed ID: 15275773
[TBL] [Abstract][Full Text] [Related]
38. The putative OP(4) antagonist, [Nphe(1)]nociceptin(1-13)NH(2), prevents the effects of nociceptin in neuropathic rats.
Corradini L; Briscini L; Ongini E; Bertorelli R
Brain Res; 2001 Jun; 905(1-2):127-33. PubMed ID: 11423087
[TBL] [Abstract][Full Text] [Related]
39. The modulatory effect of (+)-TAN-67 on the antinociceptive effects of the nociceptin/orphanin FQ in mice.
Kamei J; Ohsawa M; Suzuki T; Saitoh A; Endoh T; Narita M; Tseng LF; Nagase H
Eur J Pharmacol; 1999 Nov; 383(3):241-7. PubMed ID: 10594315
[TBL] [Abstract][Full Text] [Related]
40. Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor.
Peng YL; Chang M; Dong SL; Li W; Han RW; Fu GX; Chen Q; Wang R
Regul Pept; 2006 May; 134(2-3):75-81. PubMed ID: 16516988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
